Inhibitors of neprilysin: design, pharmacological and clinical applications.
Roques
B P
BP
Département de Pharmacochimie Moléculaire et Structurale, Institut National de la Santé et de la Recherche Medicale, Centre National de la Recherche Scientifique, Université René Descartes, Paris, France.
Noble
F
F
Crine
P
P
Fournié-Zaluski
M C
MC
D000595:Amino Acid Sequence; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000037:antagonists & inhibitors; D001519:Behavior / Q000187:drug effects; D001665:Binding Sites; D018826:CD13 Antigens / Q000378:metabolism; D015195:Drug Design; D004361:Drug Tolerance; D004745:Enkephalins / Q000378:metabolism; D006801:Humans; D008969:Molecular Sequence Data; D015260:Neprilysin / Q000037:antagonists & inhibitors* / Q000378:metabolism; D010146:Pain / Q000188:drug therapy; D011480:Protease Inhibitors / Q000009:adverse effects / Q000494:pharmacology
D000806:Angiotensin-Converting Enzyme Inhibitors; D004745:Enkephalins; D011480:Protease Inhibitors; D009320:Atrial Natriuretic Factor; D018826:CD13 Antigens; D015260:Neprilysin